Skip to main content

Table 1 Baseline characteristics of patients with chemotherapy and no-chemotherapy

From: Adjuvant chemotherapy and survival in males aged 70 years or older with breast cancer: a population-based retrospective study

Characteristics

No-Chemotherapy (n = 1652)

 

Chemotherapy (n = 248)

 

Total

(n = 1900)

 

P c

No

%

No

%

No

%

Median follow-up (months)

(Interquartile Range)

186 (164–208)

 

102 (81–123)

 

174 (153–195)

  

Race

White

1436

86.9

 

206

83.1

 

1642

86.4

 

0.196

Black

143

8.7

 

30

12.1

 

173

9.1

  

Other a

73

4.4

 

12

4.8

 

85

4.5

  

Marital status

Married

1113

67.4

 

183

73.8

 

1296

68.2

 

0.127

Not married b

469

28.4

 

56

22.6

 

525

27.6

  

Missing

70

4.2

 

9

3.6

 

79

4.2

  

Laterality

Left

836

50.6

 

133

53.6

 

969

51.0

 

0.374

Right

816

49.4

 

115

46.4

 

931

49.0

  

Histology

Ductal

1275

77.2

 

207

83.5

 

1482

78.0

 

0.026

Other d

377

22.8

 

41

16.5

 

418

22.0

  

Grade

Well

181

11.0

 

7

2.8

 

188

9.9

 

< 0.001

Moderately

649

39.3

 

103

41.5

 

752

39.6

  

Poorly/undifferentiated

424

25.7

 

100

40.3

 

524

27.6

  

Missing

398

24.1

 

38

15.3

 

436

22.9

  

Stage

I

533

32.3

 

28

11.3

 

561

29.5

 

< 0.001

II

566

34.3

 

107

43.1

 

673

35.4

  

III

192

11.6

 

91

36.7

 

283

14.9

  

Missing

361

21.9

 

22

8.9

 

383

20.2

  

Tumor size

T1

689

41.7

 

74

29.8

 

763

40.2

 

< 0.001

T2

477

28.9

 

117

47.2

 

594

31.3

  

T3/4

120

7.3

 

32

12.9

 

152

8.0

  

Missing

366

22.2

 

25

10.1

 

391

20.6

  

Nodal status

N0

893

54.1

 

68

27.4

 

961

50.6

 

< 0.001

N1

274

16.6

 

82

33.1

 

356

18.7

  

N2/3

115

7.0

 

73

29.4

 

188

9.9

  

Missing

370

22.4

 

25

10.1

 

395

20.8

  

Estrogen Receptor

Positive

1047

63.4

 

197

79.4

 

1244

65.5

 

< 0.001

Negative

31

1.9

 

7

2.8

 

38

2.0

  

Missing

574

34.7

 

44

17.7

 

618

32.5

  

Progesterone Receptor

Positive

964

58.4

 

175

70.6

 

1139

59.9

 

< 0.001

Negative

100

6.1

 

25

10.1

 

125

6.6

  

Missing

588

35.6

 

48

19.4

 

636

33.5

  

Surgery

approach

Breast Conserving Surgery

119

7.2

 

6

2.4

 

125

6.6

 

< 0.001

Mastectomy

791

47.9

 

180

72.6

 

971

51.1

  

Missing

742

44.9

 

62

25.0

 

804

42.3

  

Radiation

status

No

1374

83.2

 

150

60.5

 

1524

80.2

 

< 0.001

Yes

278

16.8

 

98

39.5

 

376

19.8

  
  1. Note:
  2. a Other includes American Indian/Alaskan native and Asian/Pacific Islander and Unknown
  3. b Not married includes divorced, separated, single (never married), unmarried or domestic partner, and widowed
  4. c The P value of the Chi-square test was calculated between the chemotherapy and without chemotherapy groups, and bold type indicates significance
  5. d Other represents all pathological types other than invasive ductal breast cancer, including invasive lobular carcinoma, medullary carcinoma, mucinous carcinoma, intraductal papilloma, papillary carcinoma, tubular carcinoma, and so on